TY  - GEN
AU  - Kuiper,Justine L
AU  - Heideman,Danielle A M
AU  - Würdinger,Tom
AU  - Grünberg,Katrien
AU  - Groen,Harry J M
AU  - Smit,Egbert F
TI  - Rationale and study design of the IRENE-trial (NVALT-16): a phase II trial to evaluate iressa rechallenge in advanced NSCLC patients with an activating EGFR mutation who responded to an EGFR-TKI used as first-line or previous treatment
SN  - 1938-0690
PY  - 2015///0730
KW  - Antineoplastic Protocols
KW  - Carcinoma, Non-Small-Cell Lung
KW  - drug therapy
KW  - Clinical Trials as Topic
KW  - Drug Resistance, Neoplasm
KW  - ErbB Receptors
KW  - genetics
KW  - Gefitinib
KW  - Humans
KW  - Lung Neoplasms
KW  - Mutation
KW  - Prospective Studies
KW  - Protein Kinase Inhibitors
KW  - administration & dosage
KW  - Quinazolines
KW  - Research Design
KW  - Survival Analysis
KW  - Withholding Treatment
N1  - Publication Type: Clinical Trial, Phase II; Journal Article; Multicenter Study
UR  - https://doi.org/10.1016/j.cllc.2014.07.008
ER  -